Indobufen in the Prevention of Thromboembolic Complications in Patients With Heart Disease. A Randomized, Placebo-Controlled, Double-Blind Study

Circulation - United States
doi 10.1161/01.cir.87.1.162
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Hepatitis Monthly
HepatologyInfectious Diseases
2016English

Randomized, Double-Blind, Placebo-Controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease

Scientific Reports
Multidisciplinary
2019English

A Double - Blind, Placebo - Controlled, Randomized Study Comparing Quetiapine With Placebo, Along With Oral Naltrexone, in the Treatment of Opioid Dependent Patients

Journal of Evolution of Medical and Dental Sciences
2015English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

A Randomized, Double-Blind, Placebo-Controlled Study of Oral Antioxidant Supplement Therapy in Patients With Dry Eye Syndrome

Clinical Ophthalmology
Ophthalmology
2016English

Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)

Cephalalgia
MedicineNeurology
2020English

Placebo Effect of Medication Cost in Parkinson Disease: A Randomized Double-Blind Study

Neurology
Neurology
2015English

Therapeutic Effect of Oral CF101 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

Immunome Research
2014English

ADHD and EEG-neurofeedback: A Double-Blind Randomized Placebo-Controlled Feasibility Study

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy